Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma

被引:51
|
作者
Huhta, Heikki [1 ,2 ,4 ,5 ]
Helminen, Olli [1 ,2 ,4 ,5 ]
Lehenkari, Petri P. [2 ,3 ,4 ,5 ]
Saarnio, Juha [2 ,4 ,5 ]
Karttunen, Tuomo J. [1 ,4 ,5 ]
Kauppila, Joonas H. [1 ,2 ,4 ,5 ]
机构
[1] Univ Oulu, Dept Pathol, Oulu 90014, Finland
[2] Univ Oulu, Dept Surg, Oulu 90014, Finland
[3] Univ Oulu, Dept Anat & Cell Biol, Oulu 90014, Finland
[4] Med Res Ctr Oulu, Oulu 90014, Finland
[5] Oulu Univ Hosp, Oulu 90029, Finland
关键词
toll-like receptor 1; toll-like receptor 2; toll-like receptor 4; toll-like receptor 6; esophageal adenocarcinoma; EXPRESSION; TLR4; GROWTH;
D O I
10.18632/oncotarget.8151
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Toll-like receptors (TLRs) recognize microbial and endogenous ligands and have already shown to play a role in esophageal cancer. In this study, we evaluated especially TLRs that sense bacterial cell wall components in Barrett's esophagus, dysplasia and esophageal adenocarcinoma. Methods: TLRs 1, 2, 4 and 6 were stained immunohistochemically and assessed in esophageal specimens from patients with esophageal dysplasia (n = 30) or adenocarcinoma (n = 99). Structures and lesions were evaluated including normal esophagus (n = 88), gastric (n = 67) or intestinal metaplasia (n = 51) without dysplasia, and low-grade (n= 42) or high-grade dysplasia (n = 37), and esophageal adenocarcinoma (n = 99). Results: We found TLR1, TLR2, TLR4 and TLR6 expression in all lesions. TLR expression increased in Barrett's mucosa and dysplasia. There was profound increase of TLR expression from gastric-to intestinal-type columnar epithelium. In cancers, high nuclear and cytoplasmic staining of TLR4 associated with metastatic disease and poor prognosis. Conclusions: TLR1, TLR2, TLR4 and TLR6 are upregulated during malignant changes of esophageal columnar epithelium. Increased TLR4 expression associates with advanced stage and poor prognosis in esophageal adenocarcinoma.
引用
收藏
页码:23658 / 23667
页数:10
相关论文
共 50 条
  • [41] Indefinite Dysplasia in Barrett's Esophagus Confers a Similar Risk of Progression to High Grade Dysplasia or Esophageal Adenocarcinoma As Low Grade Dysplasia
    Callaway, Jonathan K.
    Kommineni, Vishnu Teja
    Kahn, Allon
    Pannala, Rahul
    Crowell, Michael D.
    Burdick, George E.
    Vela, Marcelo F.
    Fleischer, David E.
    Ramirez, Francisco C.
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB511 - AB511
  • [42] IMMUNOHISTOCHEMICAL EXPRESSION ANALYSIS OF MMP-1, TIMP-2 AND P53 IN BARRETT'S ESOPHAGUS, DYSPLASIA AND ESOPHAGEAL ADENOCARCINOMA
    Garcia-Varona, Alejandro
    Fernandez-Vega, Ivan
    Santos-Juanes, Jorge
    POLISH JOURNAL OF PATHOLOGY, 2021, 72 (01) : 48 - 56
  • [43] Frequent methylation of Eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma
    Zou, HZ
    Osborn, NK
    Harrington, JJ
    Klatt, KK
    Molina, JR
    Burgart, LJ
    Ahlquist, DA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 830 - 834
  • [44] Cathelicidin modulates synthesis of Toll-like Receptors (TLRs) 4 and 9 in colonic epithelium
    Marin, Maia
    Holani, Ravi
    Shah, Chaitanya B.
    Odeon, Anselmo
    Cobo, Eduardo R.
    MOLECULAR IMMUNOLOGY, 2017, 91 : 249 - 258
  • [45] OXLDL differentially influences toll-like receptors 2 and 4
    Lepper, Philipp
    Schumann, Christian
    Rasche, Maximillian
    Frank, Hedwig
    Schneider, Marion
    INFLAMMATION RESEARCH, 2007, 56 : S116 - S116
  • [46] Clinical and Endoscopic Differences Between Patients With Barrett's Esophagus Without Dysplasia and Dysplasia/Esophageal Adenocarcinoma in Latin American Population
    Bernal-Mendez, Ambrosio Rafael
    Tellez-Avila, Felix I.
    Briseno, Francisco D.
    Romano, Adriana F.
    Barreto-Zuniga, Rafael
    Martinez-Lozano, Jorge Adolfo
    Polo, Ariadna I. Ramierz
    Valdovinos-Andraca, Francisco
    GASTROENTEROLOGY, 2015, 148 (04) : S348 - S349
  • [47] Toll-Like Receptors 2/4 and Diabetic Peripheral Neuropathy
    Elzinga, Sarah
    Murdock, Benjamin
    Hayes, John M.
    Tabbey, Maegan A.
    Feldman, Eva L.
    DIABETES, 2018, 67
  • [48] Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma
    Kaz, Andrew M.
    Luo, Yanxin
    Dzieciatkowski, Slavomir
    Chak, Amitabh
    Willis, Joseph E.
    Upton, Melissa P.
    Leidner, Rom S.
    Grady, William M.
    GENES CHROMOSOMES & CANCER, 2012, 51 (04): : 384 - 393
  • [49] IL-1RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma
    Moons, LMG
    Siersema, PD
    Kuipers, EJ
    van Vliet, AHM
    Kusters, JG
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (12): : 2818 - 2818
  • [50] Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus
    Prashanthi N. Thota
    Gaurav Kistangari
    Prabhdeep Singh
    Linda Cummings
    Kaveh Hajifathalian
    Rocio Lopez
    Madhusudhan R. Sanaka
    Digestive Diseases and Sciences, 2016, 61 : 247 - 254